Revealing Clinical Design & Early Data from Lead AB001 Programme
Time: 11:30 am
day: C&S Track AM
Details:
- Understanding the mechanisms of action and optimising dose escalations
- Uncovering first in human design post phase 0
- Exploring immunological pathways stimulated
